πŸ‡ΊπŸ‡Έ FDA
Patent

US 11684570

Pharmaceutical ophthalmic compositions

granted A61KA61K31/196A61K31/4709

Quick answer

US patent 11684570 (Pharmaceutical ophthalmic compositions) held by EYE CARE NORTHWEST, PA expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EYE CARE NORTHWEST, PA
Grant date
Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/196, A61K31/4709, A61K31/496, A61K31/573